Loading...
Market
Who will be announced as Pfizer's new Chief Scientific Officer by December 31, 2024?
2
Resolution / Starting Odds
Internal candidate • 25%
External candidate from a major pharmaceutical company • 25%
External candidate from a biotech startup • 25%
Other • 25%
Pfizer's official press releases and announcements
Story
Pfizer's Chief Scientific Officer Mikael Dolsten to Step Down After 15 Years, External Search Underway
Jul 9, 2024, 11:50 AM
Pfizer announced that its Chief Scientific Officer and President of Global Research & Development, Dr. Mikael Dolsten, will step down after a more than 15-year tenure at the company. Dolsten, a key figure behind the development of Pfizer's COVID-19 vaccine, joined Pfizer in 2009 following the Wyeth acquisition, where he served as president and head of R&D. Prior to Wyeth, he held significant roles at Boehringer and AstraZeneca. Pfizer has initiated an external search for Dolsten's successor, with Dolsten remaining part of the interview team and staying through the transition. This move comes as Pfizer's C-suite undergoes multiple changes post-pandemic and amid the integration of the $43 billion Seagen merger.
View original story
Similar markets
Executive A • 25%
Executive B • 25%
Both • 25%
Neither • 25%
Pascal Soriot • 25%
New CEO • 25%
Interim CEO • 25%
Other • 25%
Chris LaCivita • 25%
Susie Wiles • 25%
A new, unknown candidate • 25%
No new head appointed • 25%
Jay Bhattacharya • 25%
Francis Collins • 25%
Rochelle Walensky • 25%
Other • 25%
Marty Makary • 25%
Another candidate • 25%
No nomination made • 25%
Other • 25%